Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2025)
Cabaletta Bio's (CABA) quarterly Interest & Investment Income came in at $1.3 million in Q4 2025, down 31.9% year-on-year from $1.9 million in Q4 2024, and down 26.66% quarter-over-quarter from $1.8 million in Q3 2025.
Cabaletta Bio (CABA) Interest & Investment Income (2018 - 2025) Analysis & Trends
Cabaletta Bio's Interest & Investment Income history runs 8 years deep, the most recent figure standing at $1.3 million for Q4 2025.
- On a quarterly basis, Interest & Investment Income fell 31.9% year-over-year to $1.3 million in Q4 2025; TTM through Dec 2025 was $6.0 million, a 39.84% decrease from a year earlier, with the FY2025 full-year figure at $6.0 million, down 39.84% from the prior year.
- Interest & Investment Income declined to $1.3 million in Q4 2025 per CABA's latest filing, from $1.8 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.0 million in Q1 2024 and bottomed at $3000.0 in Q3 2021.
- The 5-year median for Interest & Investment Income is $1.4 million (2023), against an average of $1.2 million.
- Across the five-year window, Interest & Investment Income plunged 97.56% in 2021 and surged 12100.0% in 2022, its largest moves.
- Year by year, Interest & Investment Income stood at $5000.0 in 2021, then jumped by 12100.0% to $610000.0 in 2022, then surged by 270.49% to $2.3 million in 2023, then dropped by 13.85% to $1.9 million in 2024, then plunged by 31.9% to $1.3 million in 2025.
- Per Business Quant, the three latest CABA Interest & Investment Income figures stand at $1.3 million (Q4 2025), $1.8 million (Q3 2025), and $1.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Cabaletta Bio | 184.38 Mn | 184.38 Mn | - | 1.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.41 Mn |
| Mar 31, 2025 | 1.49 Mn |
| Dec 31, 2024 | 1.95 Mn |
| Sep 30, 2024 | 2.42 Mn |
| Jun 30, 2024 | 2.68 Mn |
| Mar 31, 2024 | 2.98 Mn |
| Dec 31, 2023 | 2.26 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.40 Mn |
| Mar 31, 2023 | 1.10 Mn |
| Dec 31, 2022 | 610,000.00 |
| Sep 30, 2022 | 351,000.00 |
| Jun 30, 2022 | 150,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 5,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 10,000.00 |